Two Sigma Securities’s Editas Medicine EDIT Stock Holding History

Two Sigma Securities’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.8K	Sell	10,459 -33,411	-76%	-$70.7K	﹤0.01%	1338
2025 Q4	$89.9K	Buy	+43,870	New	+$127K	0.01%	993
2025 Q3	–	Sell	-11,402	Closed	-$25.1K	–	1548
2025 Q2	$25.1K	Buy	+11,402	New	+$18.7K	﹤0.01%	1176
2023 Q2	–	Sell	-11,626	Closed	-$84.3K	–	2908
2023 Q1	$84.3K	Buy	+11,626	New	+$103K	﹤0.01%	2226
2020 Q1	–	Sell	-32,149	Closed	-$952K	–	1593
2019 Q4	$952K	Buy	+32,149	New	+$803K	0.01%	1070

Other funds holding EDIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Two Sigma Securities's EDIT Position: Q1 2026 in Review

Two Sigma Securities reduced its Editas Medicine (EDIT) stake by 76% in Q1 2026, selling an estimated $70.7K and leaving 10,459 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1338.

Two Sigma Securities first reported a position in EDIT in Q4 2019 and has held it in 5 quarters since. The position peaked at $952K in Q4 2019. 208 funds tracked by Wall St. Rank hold EDIT as of Q1 2026.

Two Sigma Securities held 10,459 shares of Editas Medicine worth $25.8K as of Q1 2026.
Two Sigma Securities sold 33,411 Editas Medicine shares in Q1 2026, an estimated $70.7K.
Editas Medicine made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1338 holding.
Two Sigma Securities first reported a position in Editas Medicine in Q4 2019 and has held it in 5 quarters since.
Two Sigma Securities's Editas Medicine position peaked at $952K in Q4 2019.
208 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.